alpha-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma - PubMed (original) (raw)
. 2010 Nov;39(8):1254-1262.
doi: 10.1097/MPA.0b013e3181dbf647. Epub 2010 May 7.
Affiliations
- PMID: 20467342
- DOI: 10.1097/MPA.0b013e3181dbf647
alpha-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma
Hayato Fujita et al. Pancreas. 2010 Nov.
Abstract
OBJECTIVES: Pancreatic ductal adenocarcinoma (PDAC) is often characterized by a prominent desmoplastic stroma that is induced partially by alpha-smooth muscle actin (SMA)-expressing activated pancreatic stellate cells (PSCs). This study aimed to investigate the significance of alpha-SMA expression in PDAC and the correlation between alpha-SMA mRNA levels and the patient prognosis. METHODS: We obtained formalin-fixed, paraffin-embedded tissue samples from 109 patients with PDAC, who underwent pancreatectomy at our institution from 1992 to 2007. We measured alpha-SMA mRNA levels by quantitative real-time reverse transcription-polymerase chain reaction and investigated the association of alpha-SMA mRNA expression with clinicopathologic parameters and survival time. We also assessed the influence of activated PSCs on malignant behaviors of pancreatic cancer cells using in vitro experiments. RESULTS: alpha-SMA immunoreactivity was detected exclusively in the stroma of PDAC. The group with high alpha-SMA expression showed a significantly shorter survival, as shown by univariate analysis (P = 0.005) and multivariate analysis (P < 0.0001). alpha-SMA-expressing activated PSCs enhanced the invasiveness, proliferation, and colony formation of pancreatic cancer cells. CONCLUSIONS: Quantitative analysis of alpha-SMA mRNA expression using formalin-fixed, paraffin-embedded tissue samples was useful to predict the prognosis of patients with PDAC. Activated PSCs may regulate the malignant behavior of pancreatic cancer cells.
Similar articles
- Stromal heterogeneity in pancreatic cancer and chronic pancreatitis.
Haeberle L, Steiger K, Schlitter AM, Safi SA, Knoefel WT, Erkan M, Esposito I. Haeberle L, et al. Pancreatology. 2018 Jul;18(5):536-549. doi: 10.1016/j.pan.2018.05.004. Epub 2018 May 12. Pancreatology. 2018. PMID: 29778400 - Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
Haqq J, Howells LM, Garcea G, Metcalfe MS, Steward WP, Dennison AR. Haqq J, et al. Eur J Cancer. 2014 Oct;50(15):2570-82. doi: 10.1016/j.ejca.2014.06.021. Epub 2014 Aug 1. Eur J Cancer. 2014. PMID: 25091797 Review. - Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
Tsutsumi K, Sato N, Tanabe R, Mizumoto K, Morimatsu K, Kayashima T, Fujita H, Ohuchida K, Ohtsuka T, Takahata S, Nakamura M, Tanaka M. Tsutsumi K, et al. Ann Surg Oncol. 2012 Jul;19 Suppl 3:S491-9. doi: 10.1245/s10434-011-1970-2. Epub 2011 Aug 12. Ann Surg Oncol. 2012. PMID: 21837532 - Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ, Keshishian V, Law JJ, Ho JC, Favela CA, Rees P, Smith B, Mohammad S, Hwang RF, Rajapakshe K, Coarfa C, Huang S, Edwards DP, Corr SJ, Godin B, Curley SA. Ware MJ, et al. Biomaterials. 2016 Nov;108:129-42. doi: 10.1016/j.biomaterials.2016.08.041. Epub 2016 Sep 2. Biomaterials. 2016. PMID: 27627810 Free PMC article. - Role of pancreatic stellate cells and periostin in pancreatic cancer progression.
Liu Y, Du L. Liu Y, et al. Tumour Biol. 2015 May;36(5):3171-7. doi: 10.1007/s13277-015-3386-2. Epub 2015 Apr 4. Tumour Biol. 2015. PMID: 25840689 Review.
Cited by
- Cancer-associated fibroblasts as targets for immunotherapy.
Kakarla S, Song XT, Gottschalk S. Kakarla S, et al. Immunotherapy. 2012 Nov;4(11):1129-38. doi: 10.2217/imt.12.112. Immunotherapy. 2012. PMID: 23194363 Free PMC article. Review. - Multimodality Characterization of Cancer-Associated Fibroblasts in Tumor Microenvironment and Its Correlation With Ultrasound Shear Wave-Measured Tissue Stiffness in Localized Prostate Cancer.
Ageeli W, Zhang X, Ogbonnaya CN, Bray SE, Kernohan NM, Wilson J, Li C, Nabi G. Ageeli W, et al. Front Oncol. 2022 Apr 21;12:822476. doi: 10.3389/fonc.2022.822476. eCollection 2022. Front Oncol. 2022. PMID: 35530322 Free PMC article. - The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities.
Masugi Y. Masugi Y. Cancers (Basel). 2022 Jul 5;14(13):3293. doi: 10.3390/cancers14133293. Cancers (Basel). 2022. PMID: 35805064 Free PMC article. Review. - Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets.
Whittle MC, Hingorani SR. Whittle MC, et al. Gastroenterology. 2019 May;156(7):2085-2096. doi: 10.1053/j.gastro.2018.12.044. Epub 2019 Feb 2. Gastroenterology. 2019. PMID: 30721663 Free PMC article. Review. - The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.
Kung PJ, Lai TY, Cao J, Hsu LC, Chiang TC, Ou-Yang P, Tsai CY, Tsai YF, Lin CW, Chen CC, Tsai MK, Tien YW, Lee CY. Kung PJ, et al. Cancer Immunol Immunother. 2022 Mar;71(3):705-718. doi: 10.1007/s00262-021-03026-y. Epub 2021 Aug 10. Cancer Immunol Immunother. 2022. PMID: 34374812 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials